Desglymidodrine
| Clinical data | |
|---|---|
| Other names | Deglymidodrine; ST-1059; 3,6-Dimethoxy-β-hydroxy-2-phenylethylamine | 
| Drug class | α1-Adrenergic receptor agonist; Antihypotensive agent; Vasopressor | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.322.299 | 
| Chemical and physical data | |
| Formula | C10H15NO3 | 
| Molar mass | 197.234 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Desglymidodrine (developmental code name ST-1059) is the active metabolite of the prodrug antihypotensive agent midodrine. It acts as a selective α1-adrenergic receptor agonist. Desglymidodrine is formed from midodrine via deglycination.